Pages that link to "Q43990326"

The following pages link to Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment (Q43990326):

Displaying 29 items.

• Dopamine receptors: from structure to function (Q24336139) (← links)
• A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons (Q28368794) (← links)
• Does the difference between physically active and couch potato lie in the dopamine system? (Q33719306) (← links)
• Pharmacotoxicological aspects of levosulpiride (Q34720353) (← links)
• Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia (Q35101377) (← links)
• The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review (Q37690847) (← links)
• Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum (Q38348350) (← links)
• Antisense strategies in dopamine receptor pharmacology (Q38350087) (← links)
• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease (Q40299879) (← links)
• Aromatic l-amino acid decarboxylase: Biological characterization and functional role (Q40460500) (← links)
• New approaches to the drug treatment of schizophrenia (Q40524584) (← links)
• Neurotransmitter systems in schizophrenia. (Q40932666) (← links)
• The role of candidate genes in the etiology of schizophrenia (Q41278323) (← links)
• Dopamine receptors and brain function. (Q41345716) (← links)
• A Turning Point in Schizophrenia Genetics (Q41656236) (← links)
• Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine (Q42552317) (← links)
• Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists (Q42700999) (← links)
• Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment (Q44080468) (← links)
• Gradient of dopamine responsiveness to dopamine receptor agonists in subregions of the rat nucleus accumbens (Q44602611) (← links)
• Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. (Q47745861) (← links)
• D2 dopamine receptor but not AMPA and kainate glutamate receptor genes show altered expression in response to long term treatment with trans- and cis-flupenthixol in the rat brain (Q48215054) (← links)
• Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain (Q48487638) (← links)
• Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug t (Q48496355) (← links)
• Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA. (Q48502124) (← links)
• Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic l-amino acid decarboxylase mRNA levels (Q48591093) (← links)
• The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2C receptors (Q48640011) (← links)
• Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine (Q48834112) (← links)
• Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function (Q72543478) (← links)
• Effects of dopamine agonists on Cebus apella monkeys with previous long-term exposure to fluphenazine (Q73148335) (← links)